The target compounds were subjected to anti-COX-2 activity screening, and the most active compounds were further evaluated for their cytotoxicity in order to develop potent COX-2 inhibitors with good anticancer activity that might be used in cancer treatment. Here, PTGS2 is linked to cancer.